Why it Matters
The House Energy and Commerce Subcommittee on Health is set to examine the FY 2027 HHS Budget on April 21 — a hearing that arrives as Congress wrestles with sweeping Medicaid restructuring under the reconciliation process and as the Department of Health and Human Services faces mounting scrutiny over research funding cuts and leadership decisions. The budget under review funds Medicare, Medicaid, the NIH, the CDC, the FDA, and the Indian Health Service — programs that collectively touch nearly every American. What the subcommittee chooses to probe, and what HHS defends, will help shape the fiscal and policy trajectory of the federal health enterprise heading into the next fiscal year.
The comes hearing comes on the heels of President Trump nominating last week Dr. Erica Schwartz, who served as deputy surgeon general in his first administration, to serve as the next director of the Centers for Disease Control and Prevention. Over the course of the last year, the US Centers for Disease Control and Prevention has seen a traumatic shooting, abrupt leadership changes and a shattering of its image as a globally respected public health agency.
The Policy Backdrop
The hearing lands at a moment of acute tension over federal health spending. Rep. Diana DeGette (D-CO), the subcommittee's ranking member, has publicly criticized HHS leadership for what she described as "installing anti-vax conspiracy theorists throughout HHS" and "slashing NIH research funding" — pointed language that signals Democrats intend to use the budget forum as an accountability hearing, not just a line-item review.
On the appropriations side, Rep. Raul Ruiz (D-CA) highlighted in February that he helped secure $8.05 billion for Indian Health Services in Fiscal Year 2026 and $5.3 billion in advanced funding for Fiscal Year 2027 — a data point Democrats are likely to invoke when pressing on whether the administration's budget request honors those commitments.
Meanwhile, Rep. Debbie Dingell (D-MI) signaled in March that her office was actively collecting FY 2027 community project funding requests — a sign that rank-and-file members are already invested in how the appropriations picture takes shape.
The Lobbying Landscape
The industries and advocacy groups with the most at stake have been active. Lobbying disclosures filed between the second quarter of 2025 and the first quarter of 2026 show a broad cross-section of health sector players engaging on HHS budget and Labor-HHS appropriations issues.
Healthcare providers weighed in heavily. Doctors Hospital at Renaissance filed disclosures addressing Medicaid supplemental payments, graduate medical education funding, and budget reconciliation — issues directly implicated by the FY 2027 request. Northport Health Services and Sevita filed on Medicare, Medicaid, and home and community-based services.
Public health advocates were equally engaged. The Big Cities Health Coalition lobbied specifically on CDC funding in the FY 2026 Labor-HHS bill, covering immunization, injury prevention, and public health preparedness — programs whose FY 2027 trajectories will be on the table. The Association of State and Territorial Health Officials filed a $50,000 disclosure covering Labor-HHS appropriations and health legislation broadly.
Research institutions pressed on NIH. The University of Pennsylvania filed on health issues affecting academic medical systems and NIH research. The American Society of Human Genetics specifically flagged NIH reform and biomedical research funding in its disclosures.
Pharmaceutical and device companies rounded out the field. Jazz Pharmaceuticals filed a $410,000 disclosure — the largest identified — focused on FDA regulation. B. Braun Medical filed on FDA and generic pharmaceutical issues. Baxter International engaged on the Labor-HHS appropriations bill directly.
Who's Running the Hearing
The Energy and Commerce Subcommittee on Health is chaired by Rep. Buddy Carter (R-GA), with Rep. Diana Harshbarger (R-TN) serving as vice chair and Rep. Diana DeGette (D-CO) as ranking member. The full committee is chaired by Rep. Morgan Griffith (R-VA).
The subcommittee roster includes several members with medical backgrounds — Reps. Mariannette Miller-Meeks, John Joyce, Neal Dunn, Kim Schrier, and Raul Ruiz — whose clinical experience tends to sharpen questioning on public health program funding and workforce issues.
Access the Legis1 platform for comprehensive political news, data, and insights.